FDA Approved: MEGESTROL ACETATE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Upsher-Smith Laboratories' supplemental application for Megestrol Acetate (generic megestrol acetate) under ANDA 203139.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Breast Cancer
• Cancer Cachexia
• Endometrial Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

SUPPL AP for MEGESTROL ACETATE (MEGESTROL ACETATE)